Cancer BiologybioRxivPreprint
Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis
Ziqian Peng, Kirsty Hodgson, Matthew Fisher…·Jennifer Munkley
This study identifies Siglec-engaging sialoglycans as upregulated in prostate cancer and shows they can be targeted to suppress bone metastasis using a bisialidase.
3 citations